Shionogi Company Limited

Shin-etsu Chemical Co., Ltd.

Nipro Corporation

Fujimori Kogyo Co., Ltd.

Kaori Ikeda

Izumi Saitoh

Yoshio Doi

Shohei Egawa

Toyoaki Suzuki

Sakae Obara

Hiroaki Muto

Tohru Chiba

Takeshi Nizuka

Manabu Fujimoto

Koichi Miura

Shigeru Kido

Kenji Omori

Hideji Kashiwagi

Dai Sudo

Hidetoshi Myojyo

Masashi Moteki

Sumiko Mizuno

A medical container comprising a body for containing a medicament, the body of the medical container being formed of a multilayered film comprising (i) a layer formed of a linear polyolefin and (ii) a layer formed of a cyclic polyolefin adjacent to the layer (i), and the layer (i) formed of the linear polyolefin satisfying the following conditions (a) and/or (b):

Medical container and medical duplex container

A novel endermic medicament having a consistency of a gel is proposed which is formulated, as a gel base, with non-ionic water-soluble cellulose ether, e.g., methyl cellulose and hydroxypropyl methyl cellulose, modified with a modification agent containing, in the molecule, an alkyl group having 6 to 26 carbon atoms and a functional group having reactivity with the hydroxyl group in the cellulose ether, e.g., stearyl glycidyl ether, decyl glycidyl ether and cetyl epoxide. The endermic medicament formulated with the modified cellulose ether is stable by virtue of the very little interaction between the active ingredients and the gel base and also can exhibit high percutaneous absorptivity of the active ingredients through the human skin.

Endermic medicament with a gel base

A pharmaceutical preparation for the treatment of tinea pedis, containing as basic components about 0.1% to about 2.5% of croconazole hydrochloride and about 1%-15% of an ethyl acrylate-methyl methacrylate copolymer in an aqueous alcohol, and if necessary, about 0.1% to about 2.5% of a thickening agent and/or a plasticizer.

Pharmaceutical preparation for tinea pedis

Film-formation-type antifungal preparations for external application, consisting essentially of about 0.1% to about 1.5% of tolnaphtate, about 10% to about 20% of a dimethylaminoethyl methacrylate-methacrylic acid ester copolymer and 0.5% to about 10% of a medium chain fatty acid ester in an alcoholic solvent but containing practically no water.

Film-formation-type antifungal preparation

Growing community of inventors

Osaka, Japan

Kaori Ikeda